GS
ABBV icon

GTS Securities’s AbbVie ABBV Stock Holding History

GTS Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$899K Sell
3,574
-2,819
-44% -$606K 0.02% 478
2026
Q1 		$1.39M Sell
6,393
-12,357
-66% -$2.74M 0.05% 282
2025
Q4 		$4.28M Buy
18,750
+10,631
+131% +$2.42M 0.15% 102
2025
Q3 		$1.88M Sell
8,119
-2,628
-24% -$535K 0.07% 215
2025
Q2 		$1.99M Sell
10,747
-9,792
-48% -$1.82M 0.09% 180
2025
Q1 		$4.3M Buy
20,539
+12,124
+144% +$2.36M 0.19% 77
2024
Q4 		$1.5M Sell
8,415
-14,907
-64% -$2.74M 0.07% 209
2024
Q3 		$4.61M Buy
23,322
+14,143
+154% +$2.64M 0.01% 947
2024
Q2 		$1.57M Buy
9,179
+6,515
+245% +$1.08M ﹤0.01% 1693
2024
Q1 		$485K Sell
2,664
-92,364
-97% -$15.9M ﹤0.01% 2610
2023
Q4 		$14.7M Buy
95,028
+81,506
+603% +$11.9M 0.03% 448
2023
Q3 		$2.02M Buy
+13,522
New +$1.99M ﹤0.01% 1512

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GTS Securities's ABBV Position: Q2 2026 in Review

GTS Securities reduced its AbbVie (ABBV) stake by 44% in Q2 2026, selling an estimated $606K and leaving 3,574 shares worth $899K. The position accounts for 0.02% of the portfolio, ranked #478.

GTS Securities first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. The position peaked at $14.7M in Q4 2023. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • GTS Securities held 3,574 shares of AbbVie worth $899K as of Q2 2026.
  • GTS Securities sold 2,819 AbbVie shares in Q2 2026, an estimated $606K.
  • AbbVie made up 0.02% of GTS Securities's portfolio in Q2 2026, its #478 holding.
  • GTS Securities first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • GTS Securities's AbbVie position peaked at $14.7M in Q4 2023.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.